<DOC>
	<DOCNO>NCT00712270</DOCNO>
	<brief_summary>This study conduct find way predict individual schizophrenic patient respond treated different type antipsychotic drug . This could help doctor prescribe medication work best individual .</brief_summary>
	<brief_title>Best Event Schizophrenia Trial -- A Randomized Double-Blind Trial Aripiprazole Risperidone Schizophrenia</brief_title>
	<detailed_description>The primary objective propose research project identify practical method predict differential antipsychotic drug treatment response patient schizophrenia . In particular , examine differential response two antipsychotic drug , aripiprazole risperidone , contrast pharmacologic activity D2-type dopamine receptor , i.e. , partial agonism vs. antagonism , respectively . A number candidate predictor examine , include neuroimaging parameter ( regional neuroanatomical metabolic variation , fallypride bind D2-like receptor ) , neuropsychological testing , clinical feature , laboratory measure , genetic study . Secondary objective include : ( 1 ) extension previous effort characterize abnormality cortico-striato-thalamic circuit unmedicated schizophrenic use PET MR imaging ; , ( 2 ) examination role omega-3 fatty acid activity schizophrenic predictor dopaminergic activity .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>1 . Subjects meet DSMIV diagnostic criterion schizophreniform disorder , schizophrenia , schizoaffective disorder ( nonaffective ) psychotic disorder , NOS . Subjects schizophreniform disorder psychotic disorder , NOS , diagnostically reevaluate ( recontacted longer involved study ) minimum six month psychotic symptom order determine whether diagnostic criterion schizophrenia schizoaffective disorder meet . 2 . Subjects 18 55 year age , inclusive . 3 . Subjects able fully participate informed consent process , legal guardian able participate inform consent process . 4 . Present score least one PANSS psychosis item ( P1 , P2 , P3 , P5 P6 ) &gt; 4 ( moderately severe ) CGI Severity score &gt; 4 ( moderate ) . 5 . Female patient childbearing potential must use medically accept mean contraception 1 . Current active substance use disorder diagnosis history cocaine abuse dependence ; 2 . Female patient either pregnant nursing ; 3 . Known history mental retardation , seizure disorder , clinically significant head injury ( prolonged loss consciousness , neurological sequela , demonstrate structural brain injury ) ; 4 . NonEnglish speaking ( mastery English insufficient participate study evaluation procedure ) ; 5 . Serious , unstable medical illness ; 6 . Known hypersensitivity study medication ; 7 . Medical contraindication element study procedure ; 8 . Current symptoms present serious risk danger self others ; 9 . Participation clinical trial investigational drug within 30 day study entry ; 10 . Current severity psychiatric symptom contraindicate delay initiation antipsychotic medication treatment functional imaging study neuropsychological test complete ; 11 . Baseline QTc interval &gt; 450 msec .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Antipsychotic drug treatment response</keyword>
	<keyword>Risperidone</keyword>
	<keyword>Aripiprazole</keyword>
	<keyword>Fallypride</keyword>
	<keyword>Positron emission tomography</keyword>
	<keyword>Magnetic Resonance Imaging</keyword>
	<keyword>Dopamine D2 Receptors</keyword>
</DOC>